{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T10:52:26Z","timestamp":1648551146414},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"29","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1097\/md.0000000000001200","type":"journal-article","created":{"date-parts":[[2015,7,22]],"date-time":"2015-07-22T12:51:09Z","timestamp":1437569469000},"page":"e1200","source":"Crossref","is-referenced-by-count":1,"title":["Idiopathic Pneumonia Syndrome and Thrombotic Microangiopathy Following Nonmyeloablative Haploidentical Peripheral Blood Stem Cell Transplantation and Posttransplant Cyclophosphamide"],"prefix":"10.1097","volume":"94","author":[{"given":"Wei-Hsin","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Hua","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-Long","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-27-20210309","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"R2-27-20210309","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.bbmt.2014.02.001","article-title":"Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamide.","volume":"20","author":"Castagna","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"R3-27-20210309","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.bbmt.2008.08.014","article-title":"Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following non-myeloablative conditioning for relapsed or refractory Hodgkin lymphoma.","volume":"14","author":"Burroughs","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"R4-27-20210309","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/bmt.2013.166","article-title":"Unmanipulated haploidentical BMT following non-myeloablative conditioning and post-transplantation CY for advanced Hodgkins lymphoma.","volume":"49","author":"Raiola","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"R5-27-20210309","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/bmt.2014.197","article-title":"Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas.","volume":"49","author":"Castagna","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"R6-27-20210309","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1200\/JCO.2008.20.3778","article-title":"Phase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkins disease: a Childrens Oncology Group report.","volume":"27","author":"Cole","year":"2009","journal-title":"J Clin Oncol"},{"key":"R7-27-20210309","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1164\/rccm.2007-413ST","article-title":"An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome.","volume":"183","author":"Panoskaltsis-Mortari","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"R8-27-20210309","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","article-title":"Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation.","volume":"90","author":"Cho","year":"2010","journal-title":"Transplantation"},{"key":"R9-27-20210309","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/bmt.2014.62","article-title":"T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor.","volume":"49","author":"Bashey","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"R10-27-20210309","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1172\/JCI119612","article-title":"The critical early proinflammatory events associated with idiopathic pneumonia syndrome in irradiated murine allogeneic recipients are due to donor T cell infusion and potentiated by cyclophosphamide.","volume":"100","author":"Panoskaltsis-Mortari","year":"1997","journal-title":"J Clin Invest"},{"key":"R11-27-20210309","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1164\/ajrccm\/147.6_Pt_1.1393","article-title":"Clinical course of idiopathic pneumonia after bone marrow transplantation.","volume":"147","author":"Crawford","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"R12-27-20210309","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.beha.2008.02.002","article-title":"Vascular endothelium as novel target of graft-versus-host disease.","volume":"21","author":"Tichelli","year":"2008","journal-title":"Best Pract Res Clin Haematol"},{"key":"R13-27-20210309","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/01.tp.0000230373.82376.46","article-title":"Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.","volume":"82","author":"Uderzo","year":"2006","journal-title":"Transplantation"},{"key":"R14-27-20210309","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/bmt.2014.17","article-title":"Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus.","volume":"49","author":"Labrador","year":"2014","journal-title":"Bone Marrow Transplant"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000001200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:47:12Z","timestamp":1620960432000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201507040-00027"}},"subtitle":["A Case Report"],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":14,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000001200","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}